{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:44:28Z","timestamp":1761828268929,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jiac.2025.102828","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:41:57Z","timestamp":1760139717000},"page":"102828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics and risk factors for severe disease among hospitalized patients with COVID-19 in Japan after cessation of public funding: A single-center retrospective study in 2024\u20132025"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3919-8830","authenticated-orcid":false,"given":"Chie","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Nukui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Hamashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitaro","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2123-6122","authenticated-orcid":false,"given":"Tetsuhiro","family":"Yamano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1595-8524","authenticated-orcid":false,"given":"Tohru","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7723-8960","authenticated-orcid":false,"given":"Koichi","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2025.102828_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2025.1498445","article-title":"COVID-19 clinical presentation, management, and epidemiology: a concise compendium","volume":"13","author":"Maison","year":"2025","journal-title":"Front Public Health"},{"year":"2024","series-title":"Overview of vital statistics monthly report and annual estimate (provisional figures) for Reiwa 6","key":"10.1016\/j.jiac.2025.102828_bib2"},{"key":"10.1016\/j.jiac.2025.102828_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2025.107958","article-title":"Risk of severe outcomes from COVID-19 in comorbid populations in the Omicron era: a systematic review and meta-analysis","author":"Chapman","year":"2025","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2025.102828_bib4","article-title":"COVID-19 hospitalisations in immunocompromised individuals in the Omicron era: a population-based observational study using surveillance data in British Columbia, Canada","volume":"20","author":"Bahremand","year":"2023","journal-title":"Lancet Reg Health Am"},{"key":"10.1016\/j.jiac.2025.102828_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jhin.2025.01.008","article-title":"Healthcare-associated COVID-19 infections and mortality","volume":"158","author":"Langlete","year":"2025","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jiac.2025.102828_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiac.2025.102721","article-title":"Inpatient burden of COVID-19 in Japan: a retrospective cohort study","volume":"31","author":"Andersen","year":"2025","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2025.102828_bib8","unstructured":"Analysis of COVID-19-related mortality using information from death certificates (or postmortem examination reports). Ministry of Health, Labour and Welfare [in Japanese], https:\/\/www.mhlw.go.jp\/stf\/covid-19\/00001.html [accessed September 20, 2025]."},{"key":"10.1016\/j.jiac.2025.102828_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac502","article-title":"Early outpatient treatment with remdesivir in patients at high risk for severe COVID-19: a prospective cohort study","volume":"9","author":"Rajme-L\u00f3pez","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jiac.2025.102828_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29434","article-title":"Effectiveness of nirmatrelvir-ritonavir on severe outcomes of COVID-19 in the era of vaccination and Omicron: an updated meta-analysis","volume":"96","author":"Ombelet","year":"2024","journal-title":"J Med Virol"},{"key":"10.1016\/j.jiac.2025.102828_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiac.2024.12.016","article-title":"Molnupiravir for high-risk adults with COVID-19: target trial emulation in a Japanese cohort","volume":"31","author":"Kimura","year":"2025","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2025.102828_bib12","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1007\/s40121-024-01010-4","article-title":"Real-world effectiveness of ensitrelvir in reducing severe outcomes in outpatients at high risk for COVID-19","volume":"13","author":"Takazono","year":"2024","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.jiac.2025.102828_bib14","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/13696998.2025.2461897","article-title":"Willingness to pay for the effect of SARS-CoV-2 antivirals in preventing COVID-19 transmission to others in the Japanese population","volume":"28","author":"Igarashi","year":"2025","journal-title":"J Med Econ"},{"key":"10.1016\/j.jiac.2025.102828_bib15","unstructured":"Number of SARS-CoV-2 vaccinations during the special provisional vaccination period. Ministry of Health, Labour and Welfare [in Japanese], https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/kenkou_iryou\/kenkou\/kekkaku-kansenshou\/yobou-sesshu\/syukeihou_00002.html (accessed September 20, 2025)."},{"key":"10.1016\/j.jiac.2025.102828_bib16","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1111\/jgs.18852","article-title":"Aspiration pneumonia was the most frequent cause of death in older patients with SARS-CoV-2 omicron-related pneumonia in Japan","volume":"72","author":"Miyashita","year":"2024","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jiac.2025.102828_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12931-024-02723-3","article-title":"Impact of preexisting interstitial lung disease on mortality in COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study","volume":"25","author":"Miyashita","year":"2024","journal-title":"Respir Res"},{"year":"2022","series-title":"J-SPEED:Surveillance in post extreme emergencies and disasters, Japan version findings from the Hiroshima prefecture COVID-19 J-SPEED data: analysis of the 6th wave (preliminary report)","key":"10.1016\/j.jiac.2025.102828_bib18"},{"key":"10.1016\/j.jiac.2025.102828_bib19","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S2213-2600(22)00399-X","article-title":"Withdrawal of COVID funding compounds health inequalities","volume":"10","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.jiac.2025.102828_bib20","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/jamainternmed.2024.7452","article-title":"Severity and long-term mortality of COVID-19, Influenza, and respiratory syncytial virus","volume":"185","author":"Bajema","year":"2025","journal-title":"JAMA Intern Med"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25002259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25002259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:35:18Z","timestamp":1761827718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X25002259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1341321X25002259"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102828","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics and risk factors for severe disease among hospitalized patients with COVID-19 in Japan after cessation of public funding: A single-center retrospective study in 2024\u20132025","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102828","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102828"}}